77409
document
Zinc and copper balances in preterm infants . Preterm infants are at risk for copper and zinc depletion if sufficient quantities of these nutrients are not provided in a bioavailable form in postnatal life . The purpose of this study was to determine whether the use of a whey-predominant , 50 % medium chain triglyceride formula with relatively high concentrations of zinc and copper would promote the achievement of the in utero accretion rate for zinc and copper in the preterm infant . Two groups of five preterm infants were fed a diet containing 12.5 mg/L of zinc and either 0.9 mg/L or 2.1 mg/L of copper . Seventy-two-hour metabolic balance studies were performed at an average postconceptual age of 34 weeks and an average weight of 1,549 g. All infants were in positive zinc balance and nine of ten achieved the in utero accretion rate for zinc for a 34-week gestation fetus ( greater than or equal to 0.432 mg/d ) . Three infants receiving the high copper formula and two receiving the lower copper formula were in positive copper balance . Two infants from each group achieved the in utero accretion rate for copper for a 34-week gestation fetus ( 0.088 mg/d ) . A formula that provides 12.5 mg/L of zinc permits positive zinc balance and zinc retention similar to in utero rates . A formula that provides as much as 2.1 mg/L of copper , however , may not always permit positive copper balance .
77410
Intervention_Pharmacological
Zinc and copper balances
77411
Intervention_Pharmacological
whey-predominant , 50 % medium chain triglyceride formula with relatively high concentrations of zinc
77412
Intervention_Pharmacological
copper
77413
Intervention_Pharmacological
12.5 mg/L of zinc
77414
Intervention_Pharmacological
0.9 mg/L or 2.1 mg/L of copper .
77415
Outcome_Physical
Zinc and copper balances
77416
Outcome_Physical
in utero accretion rate for zinc and copper
77417
Outcome_Physical
positive zinc balance
77418
Outcome_Physical
in utero accretion rate for zinc
77419
Outcome_Physical
positive copper balance
77420
Outcome_Physical
positive zinc balance and zinc retention
77421
Participant_Condition
preterm
77422
Participant_Age
infants
77423
Participant_Age
infants
77424
Participant_Condition
preterm
77425
Participant_Age
infant
77426
Participant_Sample-size
five